RSA Conference, the world's leading information security conferences and expositions, today announced its initial line-up of keynote speakers for its upcoming Conference, taking place at the...

Clearday, Inc. (OTCQB: CLRD) innovative care solutions will be presented by Invento Research, Inc. as part of their joint venture in the Wipro booth at the Amazon Web Services (AWS) re: Invent...

Intensity Therapeutics, Inc. ("Intensity"), a clinical-stage biotechnology company focused on the discovery and development of proprietary, novel immune-based intratumoral cancer therapies...

NeoTX Therapeutics (NeoTX), a clinical-stage immuno-oncology company, announced that the preclinical data on naptumomab estafenatox (NAP) enhancing the potency of CAR-T cells was presented on Nov...

GT Biopharma, Inc. (the "Company") (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Company's proprietary natural killer (NK)...